Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
Ralf Ludwig, Director of the Lübeck Institute of Experimental Dermatology at the University of Lübeck, shared a post on LinkedIn:
”New Research Topic at Frontiers in Immunology – and we want your best RWD and immunology work.
‘Real-world advances in inflammatory diseases: from population data to immunological mechanisms and clinical impact’
The premise: Population-scale data is most powerful when paired with mechanistic insight.
We’re looking for studies that do both – whether that’s comparative effectiveness of biologics, immune biomarkers at scale, comorbidity mapping, or methods work on causal inference in observational cohorts.
TriNetX, UK Biobank, NHIRD, Clalit, national registries – all welcome.
Editors: Shuo-Yan Gau (Charité), Ralf Ludwig (Lübeck), Uazman Alam (Liverpool), Philip Curman (Karolinska).
Deadline for submission – 4 December 2026.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care